Exelixis Past Earnings Performance

Past criteria checks 4/6

Exelixis's earnings have been declining at an average annual rate of -17%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 16.9% per year. Exelixis's return on equity is 16.5%, and it has net margins of 17.4%.

Key information

-17.0%

Earnings growth rate

-18.4%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate16.9%
Return on equity16.5%
Net Margin17.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

May 07
Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

Recent updates

Getting In Cheap On Exelixis, Inc. (NASDAQ:EXEL) Might Be Difficult

Sep 02
Getting In Cheap On Exelixis, Inc. (NASDAQ:EXEL) Might Be Difficult

Exelixis Comes Up Aces

Aug 08

If EPS Growth Is Important To You, Exelixis (NASDAQ:EXEL) Presents An Opportunity

Jun 14
If EPS Growth Is Important To You, Exelixis (NASDAQ:EXEL) Presents An Opportunity

It's Unlikely That Exelixis, Inc.'s (NASDAQ:EXEL) CEO Will See A Huge Pay Rise This Year

May 24
It's Unlikely That Exelixis, Inc.'s (NASDAQ:EXEL) CEO Will See A Huge Pay Rise This Year

Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

May 07
Exelixis' (NASDAQ:EXEL) Strong Earnings Are Of Good Quality

Exelixis: With Patent Litigation Decision Due Soon, There Are Options

May 02

Exelixis, Inc.'s (NASDAQ:EXEL) Earnings Haven't Escaped The Attention Of Investors

Apr 22
Exelixis, Inc.'s (NASDAQ:EXEL) Earnings Haven't Escaped The Attention Of Investors

Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024

Mar 28

We Ran A Stock Scan For Earnings Growth And Exelixis (NASDAQ:EXEL) Passed With Ease

Feb 26
We Ran A Stock Scan For Earnings Growth And Exelixis (NASDAQ:EXEL) Passed With Ease

Exelixis: Bullish Despite The High Stakes Game Of Cabometyx Patent Battles

Jan 17

Exelixis, Inc.'s (NASDAQ:EXEL) Revenues Are Not Doing Enough For Some Investors

Dec 27
Exelixis, Inc.'s (NASDAQ:EXEL) Revenues Are Not Doing Enough For Some Investors

An Intrinsic Calculation For Exelixis, Inc. (NASDAQ:EXEL) Suggests It's 49% Undervalued

May 30
An Intrinsic Calculation For Exelixis, Inc. (NASDAQ:EXEL) Suggests It's 49% Undervalued

Revenue & Expenses Breakdown

How Exelixis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:EXEL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,0143505161,016
31 Mar 241,8472055251,038
31 Dec 231,8302085431,044
30 Sep 231,774925311,136
30 Jun 231,7141645071,002
31 Mar 231,664154488969
31 Dec 221,611182460892
30 Sep 221,638308440777
30 Jun 221,555273426742
31 Mar 221,521298402691
31 Dec 211,435231402694
30 Sep 211,254164385626
30 Jun 211,15794371639
31 Mar 211,03165333605
31 Dec 20988112293548
30 Sep 20958152269488
30 Jun 20998282232409
31 Mar 20979294231376
31 Dec 19968321228337
30 Sep 19956612223300
30 Jun 19910642219247
31 Mar 19856650212208
31 Dec 18854690206182
30 Sep 18745368200157
30 Jun 18672323190141
31 Mar 18585253179127
31 Dec 17452154159112
30 Sep 17410150126104
30 Jun 173205812095
31 Mar 17257611690
31 Dec 16191-7011696
30 Sep 16124-14712096
30 Jun 1671-181106101
31 Mar 1643-18683103
31 Dec 1537-1625796
30 Sep 1535-17850113
30 Jun 1531-19542130
31 Mar 1530-22946157
31 Dec 1425-26151189
30 Sep 1422-28155199
30 Jun 1421-28658203
31 Mar 1427-27555201
31 Dec 1331-24551179
30 Sep 1335-22647162

Quality Earnings: EXEL has high quality earnings.

Growing Profit Margin: EXEL's current net profit margins (17.4%) are higher than last year (9.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EXEL's earnings have declined by 17% per year over the past 5 years.

Accelerating Growth: EXEL's earnings growth over the past year (113.1%) exceeds its 5-year average (-17% per year).

Earnings vs Industry: EXEL earnings growth over the past year (113.1%) exceeded the Biotechs industry 0.5%.


Return on Equity

High ROE: EXEL's Return on Equity (16.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies